Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 54 | 34 | 59 | 68 | 66 |
| Accounts receivable | 9 | 206 | 14 | -64 | -89 |
| Other Working Capital | -169 | 97 | 135 | 3 | 141 |
| Other Operating Activity | -673 | -922 | -1,071 | -1,306 | -1,195 |
| Operating Cash Flow | $-779 | $-584 | $-862 | $-1,299 | $-1,077 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 2 | 1 | -8 | -8 |
| Other Investing Activity | 0 | 3 | 0 | 0 | 0 |
| Investing Cash Flow | $0 | $5 | $1 | $-8 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | 0 | 0 | 0 | -3 |
| Other Financing Activity | 0 | -1 | -2 | -2 | -2 |
| Financing Cash Flow | $-2 | $0 | $-1 | $-2 | $-5 |
| Exchange Rate Effect | 33 | N/A | N/A | -22 | 92 |
| Beginning Cash Position | 5,069 | 6,907 | 8,248 | 9,460 | 10,458 |
| End Cash Position | 4,321 | 5,259 | 6,907 | 8,248 | 9,460 |
| Net Cash Flow | $-781 | $-580 | $-863 | $-1,309 | $-1,089 |
| Free Cash Flow | |||||
| Operating Cash Flow | -779 | -584 | -862 | -1,299 | -1,077 |
| Capital Expenditure | N/A | N/A | N/A | -8 | -8 |
| Free Cash Flow | -779 | -584 | -862 | -1,307 | -1,085 |